BeStock  
Markets › Compare › AGIO vs VIR

AGIO vs VIR

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
AGIO · Agios Pharmaceuticals$31.25 ▼ 1.73%
VIR · Vir Biotechnology$11.78 ▲ 5.46%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

4588131174217Oct 7, '25Apr 7, '26Oct 5, '26
  • AGIO -23.5%
  • VIR +108.1%

Head to head

MetricAGIOVIR
Price$31.25$11.78
Change today▼ 1.73%▲ 5.46%
Market cap$1.87B$1.99B
Return, 3 months-29.0%+14.9%
Return, year to date+14.8%+95.4%
Return, 1 year-23.6%+110.7%
P/E (TTM)-4.5-6.7
P/B1.82.0
P/E percentile vs own 5y57th–
Dividend yield––
Revenue growth (YoY, latest qtr)+48.0%–
Net profit growth (YoY)-161.3%–
Gross margin88.3%–
Operating margin-873.9%–
Net margin-764.0%–
Return on equity––
Analyst target vs. price+67.5%+78.3%
Analyst buy share100%100%
RSI (14)3763
30-day volatility32.6%51.0%
Max drawdown, 1 year-50.9%-25.6%
Trend readLeaning bearishStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • VIR is the largest of the group by market value.
  • VIR has returned the most over the past year.
  • VIR carries the lowest trailing P/E.
  • AGIO has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top